Cumberland Pharmaceuticals (CPIX) Reports Q1 Loss of $0.09

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q1 EPS of ($0.09), versus $0.02 reported last year. Revenue for the quarter came in at $8.6 million, versus $9.6 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
• Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
• Goldman Sachs reports global fund inflows for week of July 8